Does MEPOLIZUMAB Cause Skin lesion? 173 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 173 reports of Skin lesion have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.4% of all adverse event reports for MEPOLIZUMAB.
173
Reports of Skin lesion with MEPOLIZUMAB
0.4%
of all MEPOLIZUMAB reports
2
Deaths
112
Hospitalizations
How Dangerous Is Skin lesion From MEPOLIZUMAB?
Of the 173 reports, 2 (1.2%) resulted in death, 112 (64.7%) required hospitalization.
Is Skin lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 173 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Skin lesion?
SECUKINUMAB (1,909)
ADALIMUMAB (1,507)
METHOTREXATE (1,237)
DUPILUMAB (685)
ETANERCEPT (647)
PREDNISONE (617)
TOFACITINIB (478)
INFLIXIMAB (474)
CYCLOSPORINE (380)
LENALIDOMIDE (369)
Which MEPOLIZUMAB Alternatives Have Lower Skin lesion Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE